Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration. (2017)
Attributed to:
Adaptive Clinical Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/sim.6912
PubMed Identifier: 26891942
Publication URI: http://europepmc.org/abstract/MED/26891942
Type: Journal Article/Review
Volume: 36
Parent Publication: Statistics in medicine
Issue: 2
ISSN: 0277-6715